Why the Cartiva Recall Could Be Bigger Than Anyone Expected
The Expanding Fallout from the Cartiva Recall
When Stryker Corporation announced a nationwide recall of the Cartiva Synthetic Cartilage Implant in late 2024, it seemed at first like a limited correction-a product quietly withdrawn due to “performance concerns.” But as more information emerges, it’s becoming clear that this is no ordinary recall. The number of affected patients, the scope of the failures, and the legal consequences could make the Cartiva case one of the largest medical device litigations of the decade.
Thousands of people across the United States received this implant believing it was a safe, lasting solution to big toe arthritis. Instead, many are now facing painful revision surgeries, long recoveries, and permanent loss of mobility. As lawsuits pile up, many predict that the Cartiva recall could rival past mass torts involving hip implants, hernia mesh, and transvaginal mesh in both size and impact. For the full background, see Cartiva Implant Lawsuit and Recall Overview.
How the Recall Began
The recall followed years of mounting evidence that the Cartiva implant was failing at alarming rates. Surgeons across the country reported patients returning with persistent pain, swelling, and implant migration. Many needed corrective fusion surgery-often within just one to three years of the initial operation.
In October 2024, Stryker finally issued a voluntary recall of the device, citing “performance inconsistencies.” But the company’s statement raised more questions than it answered. How long had it known about these problems? Why were so many patients still being implanted right up until the recall?
For patients and attorneys now investigating, those unanswered questions are fueling an expanding wave of litigation-and potentially exposing deep corporate accountability issues. Learn what lawyers have already uncovered in Inside the Cartiva Lawsuits.
How Many Patients Could Be Affected?
Industry analysts estimate that more than 40,000 Cartiva implants were sold in the U.S. since the device’s FDA clearance in 2016. If even a fraction of those have failed, the number of potential claimants could be massive. Early studies and lawsuit data suggest real-world failure rates of 30-60%, far higher than the 13% cited in original marketing materials.
That means tens of thousands of people may experience complications ranging from pain and swelling to complete joint collapse. With growing awareness of the recall, more patients are undergoing imaging scans or second opinions-often discovering for the first time that their implant has shifted or degraded. For details on symptoms, visit How to Tell If Your Cartiva Implant Is Failing.
In past defective device litigations, these kinds of numbers have led to nationwide multidistrict litigation (MDL). Many legal observers believe Cartiva lawsuits may soon be consolidated into an MDL to coordinate discovery, evidence, and potential settlements.
What Makes This Recall Different
Most medical device recalls involve limited batches or manufacturing errors. The Cartiva recall, however, appears to be a systemic design failure-meaning the problem exists in the very concept of the implant, not just in isolated units. That’s what makes it potentially so much larger in scope.
The implant’s hydrogel material, designed to mimic cartilage, reportedly shrinks, hardens, or sinks into bone over time. As a result, it loses its cushioning ability, causing bone-on-bone pain, swelling, and eventual joint destruction. These outcomes have been reported regardless of the surgeon, patient age, or surgical technique.
In short, the issue isn’t how the device was implanted-it’s what the device is made of. And that distinction could dramatically increase both the number of lawsuits and the potential damages involved. For a breakdown of the design flaws, see The Rise and Fall of the Cartiva Toe Implant.
Mounting Lawsuits Nationwide
Since the recall, law firms across the U.S. have begun filing lawsuits on behalf of affected patients, alleging that Stryker and its subsidiary, Cartiva, Inc., knew about the high failure rates but failed to warn the public. Early court filings include claims of defective design, negligence, failure to warn, and breach of warranty.
Lawyers are also investigating whether the company misrepresented success rates in its marketing and FDA submissions. Several surgeons have reported that the real-world outcomes in their practices were far worse than the company’s published data suggested. Internal documents uncovered during discovery could reveal whether Stryker continued to market the product despite knowing about widespread failures.
Potential Settlement Value and Litigation Scale
While it’s too early to predict exact settlement amounts, experienced product liability attorneys are comparing Cartiva to other high-profile device cases. Depending on injury severity, settlements in similar cases have ranged from $100,000 to over $500,000 per patient. With potentially tens of thousands of affected individuals, total payouts could reach into the billions.
If the litigation consolidates into an MDL, it could become one of the largest medical device cases in recent history-possibly exceeding even some of Stryker’s prior hip implant settlements. The company has already faced multi-billion-dollar payouts in other defective implant cases, giving plaintiffs hope that justice and accountability are achievable here as well. See Cartiva Lawsuit Deadlines and Settlement Eligibility.
The Human Cost Behind the Headlines
Beyond the legal and financial implications, the Cartiva recall has left real people struggling to rebuild their lives. Patients who once trusted their surgeons and believed in medical innovation are now facing chronic pain, job loss, and mounting medical bills. Many have had to undergo fusion surgery to stabilize the joint, losing the flexibility they were originally promised. Learn what this means for patients in The Real Cost of a Failed Cartiva Implant.
For these patients, the lawsuits are not just about money-they’re about accountability and acknowledgment. They want to ensure other families don’t suffer the same fate and that medical device makers prioritize safety over profits.
What Comes Next
The coming months will likely see more lawsuits filed as patients learn about the recall and experience worsening symptoms. Attorneys expect the number of cases to grow exponentially once the litigation becomes more visible and court filings start revealing internal evidence from Stryker.
If the company is found to have concealed or ignored critical data, punitive damages could also come into play-further expanding the financial exposure and public scrutiny surrounding the recall.
What Affected Patients Should Do
If you received a Cartiva implant and are experiencing pain, stiffness, or have required revision surgery, it’s critical to take action now:
- Get evaluated. Schedule an appointment with your doctor or an orthopedic specialist familiar with Cartiva failures.
- Obtain your records. Request copies of your surgical notes, imaging, and implant information to confirm the product and date of surgery.
- Document your symptoms. Keep notes on how pain or mobility issues affect your daily life.
- Contact a Cartiva attorney. Legal deadlines vary by state, so it’s important to find out whether you still have time to file a claim.
Early action can help preserve your right to compensation and ensure your case is included if the lawsuits consolidate into a nationwide settlement.
A Recall That May Redefine Medical Device Accountability
The Cartiva recall is more than just another product failure-it’s a reflection of how innovation can go wrong when safety testing takes a back seat. With tens of thousands potentially affected and mounting evidence of corporate negligence, this litigation could reshape how future medical devices are approved and monitored in the U.S.
For patients, it’s a chance to demand answers, justice, and change. And for Stryker, it may be a reckoning that extends far beyond the operating room.
Injured by a Failed Cartiva Implant? Call Alonso Krangle, LLP Today
If your Cartiva Synthetic Cartilage Implant failed or you’re experiencing pain, swelling, or stiffness after surgery, Alonso Krangle, LLP can help. Our attorneys represent patients nationwide in claims against Stryker and Cartiva, holding them accountable for defective medical devices that cause lasting harm.
Call [PHONE] or contact Alonso Krangle, LLP online for a free, no-obligation consultation. There are no upfront fees, and you pay nothing unless we win your case.
Speak with An Attorney
Submit This Form or Call 800-403-6191